Introduction: Carbapenem-Resistant Acinetobacter baumannii (CRAB) causes hospital-acquired infections in Intensive Care Units (ICU), with high resistance and mortality in critically ill patients. It is a major problem in healthcare, especially where infection control and monitoring are limited. Few treatment options exist, so early identification of risk factors is needed for appropriate patient management. Aim: To evaluate the clinical profile, risk factors, treatment patterns, and outcomes of